<?xml version="1.0" encoding="UTF-8"?>
<p>Antibodies included anti-human CD34 (clone 563), CD16 (clone 3G8), CD3 (clone UCHT1), CD4 (clone L200), CD8 (clone RPA-T8), all from BD Biosciences; CD14 (clone 61D3, Thermo Fisher Scientific, Pittsburgh, PA, USA); CD19 (clone 4G7, BD Pharmingen, San Diego, CA, USA); CD90 (clone 5E10), CD20 (clone 2H7), CD15 (clone W6D3), all from Biolegend (San Diego, CA, USA); CD133 (clone 293C3, Miltenyi Biotec, GmbH); CD45 (clone D058-1283) and CD45RA (clone 5H9), both from BD Horizon (San Jose, CA, USA).</p>
